BRIGITTE CASTEELS-RAPPAGLIOSI

ceo and founder

Brigitte is an acknowledged international business leader who combines strong commercial acumen and extensive field experience in Market Access, Funding and Reimbursement, and Public Affairs for Medical Technology, including medical devices and in vitro diagnostics. Brigitte founded BC Consulting and Solutions in 2011 to deliver personalized, inclusive and international consulting services to the innovative medical technology companies that aim to invest and expand their footprint in Europe. 

Prior to that, Brigitte developed a long-standing career in the medical devices industry, including senior executive positions in major corporations as well as innovative SMEs. 
Thanks to more than 20 years of professional activity, Brigitte engages with relevant public health authorities’ networks and decision makers across Europe, including the European institutions, on critical issues impacting the medical devices industry.
Brigitte has led successful reimbursement strategies introducing new medical devices in several western European markets such as: France, Belgium, Italy, Spain, UK, Netherlands, Germany, Austria, Switzerland and Italy. 
Brigitte is a trained pharmacist by the University of Antwerpen – Belgium.

Pascale Brasseur

Director Health Economics and Market Access 

Pascale holds a degree in Economics and a Masters in Health Economics. She has been involved in the fields of health economics, outcomes research, and reimbursement policy within the healthcare industry for over 20 years. She brings a unique perspective from having worked in and now across both the medical devices and pharmaceutical sectors. Her experience includes a 15-year tenure at Medtronic, developing Health Economics and Outcomes Research projects for a wide range of technologies in several disease areas (Cardiovascular, Spine, Pain).

Whilst focusing on EMEA countries she also thrived to obtain market access in Latin America and Asia. Before Medtronic, she served as Corporate Pharmacoeconomics Manager in a biotech company. Pascale has represented the Medical Device Industry at several multi-stakeholder initiatives and has given lectures on Market Access, HEOR , and HTA for medical devices to various audiences.

francesca natalini

MARKET ACCESS & PUBLIC AFFAIRS MANAGER ITALY

Francesca has an extended and varied background in Sales and Marketing roles within both Medical Device and Pharmaceutical international companies and is experienced in Market Access and Public Affairs with a deep understanding of the Italian Healthcare System, tender processes and key decision makers/payors within the different regional areas. Francesca’s main activity is focused on planning and execution of innovative medical devices strategies and tactics to access the Italian market at national, regional and local level, including stakeholder mapping and KOL management.

Francesca has experience with systematic reviews, meta-analysis and HTA evaluations and has collaborated with several Italian Patients Associations active in chronic disease advocacy to develop patient’s empowerment and disease awareness programs.
Francesca has a Degree in Political Sciences by the University La Sapienza (Rome), a Master in Pharmaceutical and Healthcare Management by LUISS Business School (Rome) and a Master in Market Access for Pharma and Medical Devices by ALTEMS, Università Cattolica del Sacro Cuore (Rome).

Tom Jefferson

Director Medical Affairs

Tom Jefferson OStJ, MS MCGRP FFPHM DRCOG DTM&H MCIOL.

Tom Jefferson is a physician, epidemiologist and researcher. Tom’s field of expertise is evidence synthesis applied to Cochrane and other systematic reviews and Health Technology Assessment. Tom is a Senior Associate Tutor at the University of Oxford, a researcher at the Nordic Cochrane Centre and former scientific coordinator for the production of HTA reports on non-pharmaceuticals for Agenas, the Italian National Agency for Regional Healthcare. 

As a founding member of RIHTA (the Italian regional HTA network), Tom has an extended network of contacts. Tom was scientific lead for the European EUNeHTA Joint Action 2 (Workpackage 4 – devices and diagnostics) project (2012-2015). This involved coordinating some 70 researchers from 28 agencies from 23 countries (from Estonia to Bulgaria, to Greece and Sweden). Tom carried out the same role for the previous EUNeHTA project (Joint Action 1 or JA1 with the European Commission).
TJ is a member the editorial board of BMJ Evidence Based Medicine (BMJ EBM).